- Home
- IBRX vs ACMR Comparison
IBRX vs ACMR Comparison
Compare IBRX & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- ACMR
- Stock Information
- Founded
- IBRX 2014
- ACMR 1998
- Country
- IBRX United States
- ACMR United States
- Employees
- IBRX N/A
- ACMR N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- ACMR Industrial Machinery/Components
- Sector
- IBRX Health Care
- ACMR Technology
- Exchange
- IBRX Nasdaq
- ACMR Nasdaq
- Market Cap
- IBRX 2.3B
- ACMR 2.5B
- IPO Year
- IBRX N/A
- ACMR 2017
- Fundamental
- Price
- IBRX $2.26
- ACMR $41.45
- Analyst Decision
- IBRX Strong Buy
- ACMR Buy
- Analyst Count
- IBRX 6
- ACMR 4
- Target Price
- IBRX $9.83
- ACMR $34.67
- AVG Volume (30 Days)
- IBRX 9.4M
- ACMR 995.0K
- Earning Date
- IBRX 11-10-2025
- ACMR 11-05-2025
- Dividend Yield
- IBRX N/A
- ACMR N/A
- EPS Growth
- IBRX N/A
- ACMR 31.61
- EPS
- IBRX N/A
- ACMR 1.66
- Revenue
- IBRX $56,600,000.00
- ACMR $815,166,000.00
- Revenue This Year
- IBRX $629.94
- ACMR $18.90
- Revenue Next Year
- IBRX $109.91
- ACMR $16.78
- P/E Ratio
- IBRX N/A
- ACMR $24.97
- Revenue Growth
- IBRX 4227.22
- ACMR 17.53
- 52 Week Low
- IBRX $1.83
- ACMR $13.87
- 52 Week High
- IBRX $5.88
- ACMR $45.12
- Technical
- Relative Strength Index (RSI)
- IBRX 39.09
- ACMR 56.76
- Support Level
- IBRX $2.30
- ACMR $40.13
- Resistance Level
- IBRX $2.67
- ACMR $42.92
- Average True Range (ATR)
- IBRX 0.12
- ACMR 1.80
- MACD
- IBRX -0.02
- ACMR -0.12
- Stochastic Oscillator
- IBRX 1.19
- ACMR 72.83
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About ACMR ACM Research Inc.
ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.